InvestorsHub Logo

H2R

Followers 41
Posts 2215
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Monday, 08/29/2022 10:45:10 AM

Monday, August 29, 2022 10:45:10 AM

Post# of 43835
Benzinga Article

https://www.benzinga.com/markets/penny-stocks/22/08/28663723/cvm-clinicaltrials-submission

A good recap of the situation, the basic trial data, and the next steps, including:

CEL-SCI Milestones

? Submission of data of clinicaltrials.gov – May 2022

? Presentation of abstract at ASCO – June 2022

? Appointment of Gail Naughton to Board of Directors – August 2022

? Development of clinical study report – 2022

? Request meeting with FDA to determine path forward – 2022

? Development of paper(s) for publication in peer reviewed journal – 2022

? Presentation of data package to review with FDA – 2022

? Address FDA Comments – 2022

? Submission of BLA to FDA – 2022

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News